|

Interview With Dustin Robinson

ByPsychedelic Spotlight
Dustin Robinson

Similar Posts

  • MindMed ‘s Plan to END the Opioid Epidemic (How MMED / MMEDF Could Make Billions)

    Listen, Videos

    It is an unfortunate fact that the world is dealing with a second hidden epidemic: The Opioid Crisis. Luckily, MindMed ( MMED/ MMEDF ) has a solution: 18-MC. This Psychedelic Medicines company, which may soon be uplisted to the Nasdaq, is testing it’s ibogaine derivative to heal those effected by opioid addiction, whether from fentanyl or doctors’ prescriptions. We may have a light at the end of the tunnel, and the Opioid Epidemic may be defeated. This makes MindMed one of the best stocks for 2021. How much could this be worth? Tune in to find out!

    Remember to Like, Subscribe, and SMAH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media!
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    Resources

    https://www.cdc.gov/nchs/pressroom/podcasts/20190911/20190911.htm

    https://www.ncbi.nlm.nih.gov/books/NBK541390/#:~:text=Morethan2millionpeople,diseasestraumaandsuicide.

    https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/index.html#:~:text=In2018anestimated10.3,and808000peopleusedheroin.&text=Appropriateprescribingofopioidsis,andsafetyofMedicarebeneficiaries.

    https://www.ccsa.ca/opioids#:~:text=Canadaisinthemidst,publichealthandsafetyconcern.

    https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17477

    https://www.publichealthontario.ca/-/media/documents/o/2020/opioid-mortality-covid-surveillance-report.pdf?la=en

    https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/opioid-addiction

    https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery

    https://preprod.drugfree.org/article/relapse-overdose/

    https://mindmed.co/psychedelic-inspired/#scroll_section-1

    https://americanaddictioncenters.org/meth-treatment/success-rate-for-ibogaine

    https://americanaddictioncenters.org/meth-treatment/success-rate-for-ibogaine

    https://s3.ca-central-1.amazonaws.com/ibosafe-pdf-resources/Ibogaine/Treating+drug+dependence+with+the+aid+of+ibogaine_a+retrospective+study.pdf

    https://americanaddictioncenters.org/meth-treatment/success-rate-for-ibogaine

    https://thethirdwave.co/psychedelics/ibogaine/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382526/#:~:text=Theantiaddictiondrugibogainecertainlyaffectstheheartand,ibogaine’spotentiallylifethreateningcardiotoxicity.

    https://mindmed.co/wp-content/uploads/2020/11/investor-deck.pdf

    https://www.ibogainealliance.org/18-mc/

    https://mindmed.co/wp-content/uploads/2020/11/investor-deck.pdf

    #MindMed #MMED #MMEDF #MindMedNews #OpioidEpidemic #OpioidCrisis #MindMedStock #18MC #18-MC #PsychedelicStocks

  • Andrew Yang Supports LEGALIZING PSILOCYBIN in New York (But Can He Do It?)

    Listen, Videos

    Hello psychedelic investors! Today’s episode is a bit different yet still relevant to all of us invested in the psychedelic industry!
    To summarize,
    Andrew Yang comes out Hard against the war on drugs and for legalizing psilocybin. He says “The war on drugs has been a war on people”.
    Specifically, Andrew Yang calls out the criminalization of opioid use, saying big pharma has gotten these people addicted while “generating billions of dollars of blood money”, and then we throw people in jail for the pharma industries failures.
    This is, in Yang’s eyes, not a criminal problem, but a public health problem.
    If people are addicted to something, don’t throw them in jail, get them the help that they need to treat an illness that in many cases was caused by billionaire pharma companies.
    How will Andrew Yang create a de facto decriminalization?
    He would instruct the DA not to prosecute for possession charges.
    Its that simple.
    Finally he talks about how he is for the legalization of psilocybin and open to legalize other substances.
    Yang is calling for decriminalizing the use of all drugs, AND to legalize psilocybin..

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    For any collaborations, you can reach us on our email
    email: thepsychedelicinvestor@gmail.com

    If you are thinking of joining Benzinga Pro, why not use our link, and we will both get a discount!
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #AndrewYang ​#AndrewYangMayor​​ #AndrewYangDebate

  • Interview With Dr. Steven Mandel

    Listen, Podcasts

    In this episode of the Psychedelic Spotlight podcast, we have the distinct privilege of speaking with one of the foremost experts in ketamine-assisted therapy, Dr. Steven L. Mandel, Founder and President of Ketamine Clinics Los Angeles.

  • How Risky is MindMed Stock? (MMED / MMEDF Risk Assessment)

    Listen, Videos

    Today, we have a different episode for you..Usually we talk about all the things I am excited for when it comes to MindMed and MindMed stock, but today, we will visit the darker side by discussing how risky is the MindMed stock.
    It is important for all psychedelic investors to grasp that MindMed is not a sure deal. Yes, I believe that long term it will succeed, but there are certain things that could go wrong.

    We will cover the very real risks involved in investing in MindMed such as:
    1. The possibility of MindMed’s medicines being inefficacious
    – Whether of not MMED’s clinical trials succeed
    2.MindMed’s incertain long term profitability
    – Can the company scale production and training protocols?
    3.MindMed Stock volatility
    – MindMed’s market cap
    – Future short interests

    MindMed trades on the Canadian NEO Market as (MMED) and American OTC market as (MMEDF)

    MindMed is the leader in psychedelic medicines, and is my top Psychedelic Stock. Is MindMed a buy? Is MindMed a good Investment? Watch our channel to find out!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media!
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    https://mindmed.co/wp-content/uploads/2020/11/end-of-year-2019-discussion.pdf

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own